WHITEHOUSE STATION, N.J.--Merck, known as MSD outside the United States and Canada, today said a jury found in its favor in the Glynn v. Merck case in the U.S. District Court for the District of New ...
Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, according to recent data published in the Archives of Internal Medicine. Researchers from ...
WHITEHOUSE STATION, N.J., November 23, 2009 - Merck said today that U.S. District Court Judge John F. Keenan granted summary judgment in Merck's favor in Flemings v. Merck. Flemings is the second of ...
The bisphosphonate alendronate sodium increases bone mineral density in patients with immunobullous diseases and glucocorticoid-induced osteoporosis, according to study results. The double blind, ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck today said a unanimous federal court jury in New York found in its favor in the Maley v. Merck case, rejecting the claims of a plaintiff who blamed ...
Alendronate sodium 70 mg with colecalciferol micrograms and calcium carbonate 1. Prior to treatment, osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations ...
Merck put Fosamax (alendronate sodium) and its $3 billion in total 2007 sales inits rear-view mirror yesterday, following the lapse of patent protection on theosteoporosis drug. Merck forecast that ...
In re Fosamax (Alendronate Sodium), No. 11-5304, 08-08; U.S. District Court (DNJ); opinion by Pisano, U.S.D.J.; filed June 27, 2013. DDS No. 36-7-xxxx [17 pp.] Fosamax (Alendronate Sodium) is approved ...
We have written before about the Supreme Court’s impossibility preemption decision, Merck Sharpe & Dohme Corp. v. Albrecht, 139 S. Ct. 1668 (2019) (Albrecht) (here, here, here, and here), highlighting ...
(Reuters) - A federal appeals court on Wednesday revived claims by several hundred plaintiffs who accused Merck & Co of failing to adequately warn about the risks of thigh bone fractures associated ...
BINOSTO (alendronate sodium) 70mg effervescent tablet for oral solution by Mission Pharmacal EffRx announced that the FDA has approved Binosto (alendronate sodium) Effervescent Tablets for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback